These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 36794163)

  • 1. Natural Killer Cell Activity Test Helps to Suspect Aggressive Natural Killer Cell Leukemia - Diagnostic Challenge.
    You E; Park CJ; Lee MY; Cho YU; Jang S; Lee JH; Lee JH; Lee KH
    Int J Med Sci; 2023; 20(2):206-210. PubMed ID: 36794163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A probable identical Epstein-Barr virus clone-positive composite lymphoma with aggressive natural killer-cell leukemia and cytotoxic T-cell lymphoma.
    Sugimoto KJ; Shimada A; Wakabayashi M; Imai H; Sekiguchi Y; Nakamura N; Sawada T; Ota Y; Takeuchi K; Ito Y; Kimura H; Komatsu N; Noguchi M
    Int J Clin Exp Pathol; 2014; 7(1):411-7. PubMed ID: 24427365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathological features and treatment of aggressive natural killer cell leukemia: case series and literature review.
    Ni Y; Li L; Wang Y; Sun L
    Turk J Pediatr; 2024 Oct; 66(4):481-489. PubMed ID: 39387420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aggressive natural killer cell leukemia or extranodal NK/T cell lymphoma? a case with nasal involvement.
    Jin X; Xu Y; Zhang J; Li G; Huang D; Yang Y; He H
    Diagn Pathol; 2017 Jun; 12(1):46. PubMed ID: 28623913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a novel CCDC22 mutation in a patient with severe Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis and aggressive natural killer cell leukemia.
    Yamashita Y; Nishikawa A; Iwahashi Y; Fujimoto M; Sasaki I; Mishima H; Kinoshita A; Hemmi H; Kanazawa N; Ohshima K; Imadome KI; Murata SI; Yoshiura KI; Kaisho T; Sonoki T; Tamura S
    Int J Hematol; 2019 Jun; 109(6):744-750. PubMed ID: 30706328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Possible Concomitant Aggressive NK Cell Leukemia and EBV-positive T-cell lymphoma; Using the online beta version of WHO-HAEM5 and videoconferencing software to make diagnoses accessible in an emerging economy.
    Dayton VJ; Hoang Thien D; Xinh PT; Arries C; Sang NN; Linh NNN; Lien NP; Dung PC
    Diagn Pathol; 2023 Oct; 18(1):111. PubMed ID: 37803436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flow Cytometric Immunophenotyping Is Sensitive for the Early Diagnosis of De Novo Aggressive Natural Killer Cell Leukemia (ANKL): A Multicenter Retrospective Analysis.
    Li Y; Wei J; Mao X; Gao Q; Liu L; Cheng P; Liu L; Zhang X; Zhang K; Wang J; Zhu L; Zhou J; Zhang Y; Meng L; Sun H; Li D; Huang M; Huang W; Deng J; Zhang D
    PLoS One; 2016; 11(8):e0158827. PubMed ID: 27483437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epstein-Barr virus-associated T- and NK-cell lymphoproliferative diseases: an update and diagnostic approach.
    Hue SS; Oon ML; Wang S; Tan SY; Ng SB
    Pathology; 2020 Jan; 52(1):111-127. PubMed ID: 31767131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EBV-negative Aggressive NK-cell Leukemia/Lymphoma: Clinical, Pathologic, and Genetic Features.
    Nicolae A; Ganapathi KA; Pham TH; Xi L; Torres-Cabala CA; Nanaji NM; Zha HD; Fan Z; Irwin S; Pittaluga S; Raffeld M; Jaffe ES
    Am J Surg Pathol; 2017 Jan; 41(1):67-74. PubMed ID: 27631517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The superiority of Epstein-Barr virus DNA in plasma over in peripheral blood mononuclear cells for monitoring EBV-positive NK-cell lymphoproliferative diseases.
    Zheng M; Bao Y; Wang J; Ma Y; Yang Y; Zhang P; Chen L; Zheng K; Zhou J
    Hematol Oncol; 2022 Aug; 40(3):381-389. PubMed ID: 35405763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinicopathological analysis of the age-related differences in patients with Epstein-Barr virus (EBV)-associated extranasal natural killer (NK)/T-cell lymphoma with reference to the relationship with aggressive NK cell leukaemia and chronic active EBV infection-associated lymphoproliferative disorders.
    Takahashi E; Ohshima K; Kimura H; Hara K; Suzuki R; Kawa K; Eimoto T; Nakamura S;
    Histopathology; 2011 Oct; 59(4):660-71. PubMed ID: 22014047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural killer cell malignancy associated with Epstein-Barr virus and hemophagocytic syndrome.
    Warnnissorn N; Kanitsap N; Kulkantrakorn K; Assanasen T
    J Med Assoc Thai; 2007 May; 90(5):982-7. PubMed ID: 17596056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aggressive natural killer cell leukemia with skin manifestation associated with hemophagocytic lymphohistiocytosis: A case report.
    Peng XH; Zhang LS; Li LJ; Guo XJ; Liu Y
    World J Clin Cases; 2021 Dec; 9(34):10708-10714. PubMed ID: 35005005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonnasal lymphoma expressing the natural killer cell marker CD56: a clinicopathologic study of 49 cases of an uncommon aggressive neoplasm.
    Chan JK; Sin VC; Wong KF; Ng CS; Tsang WY; Chan CH; Cheung MM; Lau WH
    Blood; 1997 Jun; 89(12):4501-13. PubMed ID: 9192774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flow cytometric immunophenotyping is of great value to diagnosis of natural killer cell neoplasms involving bone marrow and peripheral blood.
    Jiang NG; Jin YM; Niu Q; Zeng TT; Su J; Zhu HL
    Ann Hematol; 2013 Jan; 92(1):89-96. PubMed ID: 22992980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aggressive natural killer cell leukemia: is Epstein-Barr virus negativity an indicator of a favorable prognosis?
    Ko YH; Park S; Kim K; Kim SJ; Kim WS
    Acta Haematol; 2008; 120(4):199-206. PubMed ID: 19153474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Favorable outcome in a child with EBV-negative aggressive NK cell leukemia.
    Park JA; Jun KR; Nam SH; Ghim TT
    Int J Hematol; 2013 May; 97(5):673-6. PubMed ID: 23550023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequent CD7 antigen loss in aggressive natural killer-cell leukemia: a useful diagnostic marker.
    Yoo EH; Kim HJ; Lee ST; Kim WS; Kim SH
    Korean J Lab Med; 2009 Dec; 29(6):491-6. PubMed ID: 20046078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EBV-negative aggressive NK-cell leukemia/lymphoma: a clinical and pathological study from a single institution.
    Gao J; Behdad A; Ji P; Wolniak KL; Frankfurt O; Chen YH
    Mod Pathol; 2017 Aug; 30(8):1100-1115. PubMed ID: 28548121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monomorphic agranular natural killer cell lymphoma/leukemia with no Epstein-Barr virus association.
    Matano S; Nakamura S; Nakamura S; Annen Y; Hattori N; Kobayashi K; Kyoda K; Sugimoto T
    Acta Haematol; 1999; 101(4):206-8. PubMed ID: 10436303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.